Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Thursday, May 25, 2017

Oral Abstracts from 3rd European Stroke Organisation Conference (ESOC 2017)

Useless, I don't see anything that addresses the neuronal cascade of death or any useful rehab strategies. Proves once again there is no strategy to get all stroke survivors 100% recovered.
http://journals.sagepub.com/doi/full/10.1177/2396987317705236

THE NORWEGIAN TENECTEPLASE STROKE TRIAL (NOR-TEST): RANDOMISED CONTROLLED TRIAL OF TENECTEPLASE VS. ALTEPLASE IN ACUTE ISCHAEMIC STROKE

 

EFFICACY OF EARLY COGNITIVE-LINGUISTIC TREATMENT FOR APHASIA DUE TO STROKE; A RANDOMISED CONTROLLED TRIAL (RATS-3)

 

CLOSURE OF PATENT FORAMEN OVALE, ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY TO PREVENT STROKE RECURRENCE (CLOSE): A RANDOMIZED CLINICAL TRIAL

 

PROBUCOL FOR PREVENTION OF CARDIOVASCULAR EVENTS IN ISCHEMIC STROKE PATIENTS WITH HIGH RISK OF CEREBRAL HEMORRHAGE (PICASSO) STUDY: A MULTICENTER, RANDOMIZED CONTROLLED TRIAL

 

PROGNOSTIC AND TREATMENT IMPACT OF PENUMBRAL IMAGING IN POOLED ANALYSIS OF RANDOMIZED TRIALS OF ENDOVASCULAR STENT THROMBECTOMY

 

TESPI(THROMBOLYSIS IN ELDERLY STROKE PATIENTS IN ITALY): RANDOMIZED CONTROLLED TRIAL OF ALTEPLASE VERSUS STANDARD TREATMENT IN PATIENTS AGED >80 YEARS WITHIN 3HRS AFTER STROKE ONSET

 

OFF LABEL USE OF ALTEPLASE FOR ACUTE ISCHEMIC STROKE (AIS) IN PATIENTS OVER 80 YEARS OF AGE: INDIVIDUAL-PATIENT-DATA META-ANALYSIS OF EIGHT TRIALS

 

LOW-DOSE VERSUS STANDARD-DOSE ALTEPLASE BY AGE, ETHNICITY, AND SEVERITY OF ACUTE ISCHAEMIC STROKE: THE ENCHANTED TRIAL

 

THROMBOLYSIS IMPLEMENTATION IN STROKE (TIPS) TRIAL: A CLUSTER RANDOMISED CONTROL TRIAL OF IMPLEMENTATION STRATEGIES FOR INTRAVENOUS THROMBOLYSIS

 

CHARACTERISTICS, MANAGEMENT AND RESPONSE TO TREATMENT IN CHINESE VS. NON-CHINESE PARTICIPANTS IN THE ENCHANTED TRIAL

 

THE NORWEGIAN SONOTHROMBOLYSIS IN ACUTE STROKE STUDY (NOR-SASS). A RANDOMIZED CONTROLLED STUDY OF CONTRAST-ENHANCED SONOTHROMBOLYSIS

 

INTRAVENOUS THROMBOLYSIS IN PATIENTS WITH STROKE UNDER RIVAROXABAN USING DRUG SPECIFIC PLASMA LEVELS – EXPERIENCE WITH A STANDARD OPERATION PROCEDURE IN CLINICAL PRACTICE

 

PROFESSIONAL GUIDELINE VERSUS PRODUCT LICENCE SELECTION FOR TREATMENT WITH IV THROMBOLYSIS: COMPLIANCE WITH PRODUCT LICENCES IS HIGHEST IN LOWER EFFICIENCY SITES AND RESTRICTS THROMBOLYSIS USAGE

 

OUTCOME AFTER ISCHEMIC STROKE IN PATIENTS OVER 80 YEARS TREATED WITH IV THROMBOLYSIS IN THE 3–4.5H COMPARED TO 3H TIME WINDOW: RESULTS FROM SITS-ISTR

 

NON-VITAMIN-K-ANTAGONIST ORAL ANTICOAGULANTS VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND PREVIOUS STROKE OR TIA: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

 

EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS IN A POPULATION STUDY OF INCIDENT ATRIAL FIBRILLATION

 

PREDICTING RISK OF MAJOR BLEEDING IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION AFTER TIA OR STROKE: EXTERNAL VALIDATION OF RISK SCORES

 

EARLY RECURRENCE AND MAJOR BLEEDING IN PATIENTS WITH ACUTE ISCHAEMIC STROKE AND ATRIAL FIBRILLATION TREATED WITH DIRECT ORAL ANTICOAGULANTS. THE RAF-DOAC STUDY

 

EVALUATING THE EFFECTIVENESS AND SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED WITH VITAMIN-K ANTAGONISTS

 

POPULATION-BASED STUDY OF PROGNOSIS OF BRIEF EPISODES OF ATRIAL FIBRILLATION ON 5-DAY HOME CARDAIC RHYTHM MONITORING AFTER TIA AND ISCHAEMIC STROKE

 

PILOT STUDY OF CARDIAC MAGNETIC RESONANCE IMAGING IN EMBOLIC STROKE OF UNDETERMINED SOURCE (MR-ESUS)

 

COMPARATIVE EFFECTIVENESS OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AND WARFARIN IN THE SCOTTISH ATRIAL FIBRILLATION POPULATION: THE VALUE OF REAL WORLD EVIDENCE

 

PREDICTIVE FACTORS OF STROKE RECURRENCE IN PATIENTS WITH ISCHEMIC STROKE DUE TO ATRIAL FIBRILLATION

 

OPTIMAL TIMING TO START RIVAROXABAN ADMINISTRATION TO PREVENT RECURRENT EMBOLISM IN ACUTE STROKE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION (NVAF): THE RELAXED STUDY

 

NURSE-LED, TELEPHONE-BASED, SECONDARY PREVENTIVE FOLLOW-UP AFTER STROKE OR TIA IMPROVES BLOOD PRESSURE AND LDL CHOLESTEROL: THREE-YEAR RESULTS FROM THE RANDOMIZED CONTROLLED NAILED STROKE TRIAL

 

TICAGRELOR VERSUS ASPIRIN IN ACUTE EMBOLIC STROKE OF UNDETERMINED SOURCE (ESUS)

 

PRIMARY RESULTS OF EBBINGHAUS, A COGNITIVE STUDY OF PATIENTS ENROLLED IN THE FOURIER TRIAL

 

A CULTURALLY-TAILORED, SKILLS-BASED INTERVENTION TO REDUCE BLOOD PRESSURE IN A MULTI-ETHNIC GROUP OF MILD/MODERATE STROKE SURVIVORS WITH HYPERTENSION: RESULTS FROM THE DESERVE TRIAL

 

SECULAR TRENDS IN PROCEDURAL STROKE OR DEATH RISKS OF STENTING VERSUS ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS – A POOLED ANALYSIS OF RANDOMISED TRIALS

 

RESTENOSIS AFTER STENTING VERSUS ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS AND ITS RELATIONSHIP WITH RECURRENT STROKE IN THE RANDOMISED INTERNATIONAL CAROTID STENTING STUDY (ICSS)

 

ENDOVASCULAR TREATMENT VERSUS ENDARTERECTOMY FOR CAROTID ARTERY STENOSIS: RESULTS FROM THE UPDATED SYSTEMATIC COCHRANE REVIEW

 

THE EVOLUTION OF CAROTID INTERVENTION: SECULAR TRENDS IN STENT TYPE, CEREBRAL PROTECTION DEVICES AND MEDICATION IN ACST-2, A LARGE INTERNATIONAL RCT COMPARING SURGERY WITH STENTING


















































































 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

No comments:

Post a Comment